Skip to content

RxSight Light Adjustable Lens (RxLAL) 60005-3060Recalls & reported problems

Rxsight, Inc. · LAL, Sterile, Packaged, 6.0 Diopter · Class 3 · Implant

All models of RxSight Light Adjustable Lens (RxLAL) (62)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00818806020913), received between Jun 1, 2023 and Jun 3, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Optical Decentration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Optical Decentration1

Patient problems

  • Unspecified Eye / Vision Problem2
  • Blurred Vision1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 3, 2025Optical Decentration; Optical Decentration

    A SITE REPORTED TO RXSIGHT THAT A PATIENT'S LIGHT ADJUSTABLE LENS (LAL, SN (B)(6), +6.0D) WAS EXPLANTED FROM THE EYE DUE TO LENS DECENTRATION SECONDARY TO POSSIBLE ZONULAR DEHISCENCE OR A KINKED HAPTIC DURING DELIVERY OF THE LAL WHICH WAS CAUSED BY PRIOR INCOMPLETE REMOVAL OF AN IMPLANTABLE COLLAMER LENS; A NEW LAL (SN (B)(6), +6.0D) WAS IMPLANTED AS A REPLACEMENT.

    Patient problems: Unspecified Eye / Vision Problem

    MAUDE report 22137773 ↗
  • InjuryApr 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A SITE REPORTED TO RXSIGHT THAT A PATIENT'S LIGHT ADJUSTABLE LENS (LAL, SN (B)(6), +6.0D) THAT WAS INITIALLY PLACED AS A PIGGYBACK INTRAOCULAR LENS IN THE CAPSULAR BAG WAS EXPLANTED FROM THE RIGHT EYE DUE TO BLURRY VISION AND A NEW LAL (SN (B)(6), +8.0D) IMPLANTED AS A REPLACEMENT.

    Patient problems: Blurred Vision

    MAUDE report 21910600 ↗
  • InjuryJun 1, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE SITE REPORTED THAT A LIGHT ADJUSTABLE LENS (LAL SN (B)(6)) WAS EXPLANTED ON (B)(6) 2023. RXSIGHT'S FIRST AWARENESS OF THIS EVENT WAS ON (B)(6) 2023.

    Patient problems: Unspecified Eye / Vision Problem

    MAUDE report 17043647 ↗

Other Light Adjustable Lens (Lal) And Light Delivery Device (Ldd) devices

All Light Adjustable Lens (Lal) And Light Delivery Device (Ldd) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page